Michella Ghassibe-Sabbagh

Michella Ghassibe-Sabbagh

Auto-generated profile, based on publicly available information

Michella Ghassibe-Sabbagh

Department of Natural Sciences, School of Arts and Sciences, Lebanese American University, Beirut, Lebanon

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2002 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
PBPascal Brouillard
Pascal Brouillard
LBLaurence M. Boon
Laurence M. Boon
JMJohn B. Mulliken
John B. Mulliken
OEOdile Enjolras
Odile Enjolras
MGMichella Ghassibé
Michella Ghassibé
Miikka VikkulaMiikka Vikkula
Miikka Vikkula

1 January 2021 in Mutation Research - Reviews in Mutation Research
Verified
Journal Article
Closed access
GNGhenwa Nasreddine
Ghenwa Nasreddine
JHJoelle El Hajj
Joelle El Hajj
MGMichella Ghassibe-Sabbagh
Michella Ghassibe-Sabbagh

1 April 2009 in Genetics in Medicine
Verified
Journal Article
Open access
PDF file
RLRenata L. L. Ferreira de Lima
Renata L. L. Ferreira de Lima
SHSarah A. Hoper
Sarah A. Hoper
MGMichella Ghassibe
Michella Ghassibe
MCMargaret E. Cooper
Margaret E. Cooper
NRNicholas K. Rorick
Nicholas K. Rorick
BSBrian C. Schutte
Brian C. Schutte
Purpose: Interferon regulatory factor 6 encodes a member of the IRF family of transcription factors. Mutations in interferon regulatory factor 6 cause Van der Woude and popliteal pterygium syndrome, two related orofacial clefting disorders. Here, we compared and contrasted the frequency and distribution of exonic mutations in interferon regulatory factor 6 between two large geographically distinct collections of families with Van der Woude and between one collection of families with popliteal pterygium syndrome. Methods: We performed direct sequence analysis of interferon regulatory factor 6 exons on samples from three collections, two with Van der Woude and one with popliteal pterygium syndrome. Results: We identified mutations in interferon regulatory factor 6 exons in 68% of families in both Van der Woude collections and in 97% of families with popliteal pterygium syndrome. In sum, 106 novel disease-causing variants were found. The distribution of mutations in the interferon regulatory factor 6 exons in each collection was not random; exons 3, 4, 7, and 9 accounted for 80%. In the Van der Woude collections, the mutations were evenly divided between protein truncation and missense, whereas most mutations identified in the popliteal pterygium syndrome collection were missense. Further, the missense mutations associated with popliteal pterygium syndrome were localized significantly to exon 4, at residues that are predicted to bind directly to DNA. Conclusion: The nonrandom distribution of mutations in the interferon regulatory factor 6 exons suggests a two-tier approach for efficient mutation screens for interferon regulatory factor 6. The type and distribution of mutations are consistent with the hypothesis that Van der Woude is caused by haploinsufficiency of interferon regulatory factor 6. On the other hand, the distribution of popliteal pterygium syndrome-associated mutations suggests a different, though not mutually exclusive, effect on interferon regulatory factor 6 function.

31 August 2005 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
MGMichella Ghassibé
Michella Ghassibé
BBBenedicte Bayet
Benedicte Bayet
NRNicole Revencu
Nicole Revencu
CVChristine Verellen-Dumoulin
Christine Verellen-Dumoulin
YGYves Gillerot
Yves Gillerot
Miikka VikkulaMiikka Vikkula
Miikka Vikkula
Cleft lip with or without cleft palate is the most frequent craniofacial malformation in humans ( ∼ 1/700). Its etiology is multifactorial; some are a result of a genetic mutation, while others may be due to environmental factors, with genetic predisposition playing an important role. The prevalence varies widely between populations and the mode of inheritance remains controversial. The interferon regulatory factor-6 (IRF6) gene has been shown to harbor mutations in patients with van der Woude syndrome, a dominant form of clefts associated with small pits of the lower lip. Moreover IRF6 has been associated with nonsyndromic cleft of the palate (CL/P) in two separate studies. We investigated the role of IRF6 in a set of 195 trios from Belgium. Cleft occurred as an isolated feature. We studied association of the IRF6 locus using two variants: one in the IRF6 gene and the other 100 kpb 3′ of the gene. Our independent study group confirms that the IRF6 locus is associated with nonsyndromic cleft lip with or without palate. This result, with previous studies performed in the United States and Italy, shows for the first time the implication of IRF6 in isolated CL/P in northern Europe. It is likely that association to this locus can be identified in various populations and that the IRF6 locus thus represents an important genetic modifier for this multifactorial malformation.

27 December 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SSStephanie Saade
Stephanie Saade
JCJean-Baptiste Cazier
Jean-Baptiste Cazier
MGMichella Ghassibe-Sabbagh
Michella Ghassibe-Sabbagh
SYSonia Youhanna
Sonia Youhanna
DBDanielle A Badro
Danielle A Badro
TCthe FGENTCARD consortium
the FGENTCARD consortium
Genome wide association studies (GWAS) and their replications that have associated DNA variants with myocardial infarction (MI) and/or coronary artery disease (CAD) are predominantly based on populations of European or Eastern Asian descent. Replication of the most significantly associated polymorphisms in multiple populations with distinctive genetic backgrounds and lifestyles is crucial to the understanding of the pathophysiology of a multifactorial disease like CAD. We have used our Lebanese cohort to perform a replication study of nine previously identified CAD/MI susceptibility loci (LTA, CDKN2A-CDKN2B, CELSR2-PSRC1-SORT1, CXCL12, MTHFD1L, WDR12, PCSK9, SH2B3, and SLC22A3), and 88 genes in related phenotypes. The study was conducted on 2,002 patients with detailed demographic, clinical characteristics, and cardiac catheterization results. One marker, rs6922269, in MTHFD1L was significantly protective against MI (OR = 0.68, p = 0.0035), while the variant rs4977574 in CDKN2A-CDKN2B was significantly associated with MI (OR = 1.33, p = 0.0086). Associations were detected after adjustment for family history of CAD, gender, hypertension, hyperlipidemia, diabetes, and smoking. The parallel study of 88 previously published genes in related phenotypes encompassed 20,225 markers, three quarters of which with imputed genotypes The study was based on our genome-wide genotype data set, with imputation across the whole genome to HapMap II release 22 using HapMap CEU population as a reference. Analysis was conducted on both the genotyped and imputed variants in the 88 regions covering selected genes. This approach replicated HNRNPA3P1-CXCL12 association with CAD and identified new significant associations of CDKAL1, ST6GAL1, and PTPRD with CAD. Our study provides evidence for the importance of the multifactorial aspect of CAD/MI and describes genes predisposing to their etiology.

1 October 2020 in Journal of Dentistry
Verified
Journal Article
Closed access
JSJoseph Sabbagh
Joseph Sabbagh
MGMichella Ghassibe-Sabbagh
Michella Ghassibe-Sabbagh
MFMohammad Fayyad-Kazan
Mohammad Fayyad-Kazan
FAFatima Al-Nemer
Fatima Al-Nemer
JFJean Claude Fahed
Jean Claude Fahed
BBBassam Badran
Bassam Badran